Optimer Hires New CEO
San Diego-based Optimer Pharmaceuticals (NASDAQ: OPTR) has named Pedro Lichtinger as its new chief executive officer. Lichtinger will replace Michael Chang, who will continue at Optimer as chairman of the board and as a consultant, the company said in a statement. Lichtinger is a former executive from Pfizer, and was most recently the president of that company’s primary care business. Optimer is in the final stages of development with antibiotics for C.difficile bacterial infections that people get in hospitals, and another for traveler’s diarrhea.